Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.
García-Guerrero E, Götz R, Doose S, Sauer M, Rodríguez-Gil A, Nerreter T, Kortüm KM, Pérez-Simón JA, Einsele H, Hudecek M, Danhof S. García-Guerrero E, et al. Among authors: hudecek m. Leukemia. 2022 Jan;36(1):297. doi: 10.1038/s41375-021-01355-6. Leukemia. 2022. PMID: 34845317 Free PMC article. No abstract available.
Engineered T cells for anti-cancer therapy.
Turtle CJ, Hudecek M, Jensen MC, Riddell SR. Turtle CJ, et al. Among authors: hudecek m. Curr Opin Immunol. 2012 Oct;24(5):633-9. doi: 10.1016/j.coi.2012.06.004. Epub 2012 Jul 18. Curr Opin Immunol. 2012. PMID: 22818942 Free PMC article. Review.
The era of in vivo T cell engineering.
Campos Ramos G, Hudecek M. Campos Ramos G, et al. Among authors: hudecek m. Med. 2022 Feb 11;3(2):85-86. doi: 10.1016/j.medj.2022.01.012. Med. 2022. PMID: 35590210 Free article.
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris EC, O'Dwyer M, Sierra JG, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Among authors: hudecek m. Hemasphere. 2021 Sep 10;5(10):e642. doi: 10.1097/HS9.0000000000000642. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34522844 Free PMC article.
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, Wood B, Maloney DG, Jensen MC, Rader C, Riddell SR. Hudecek M, et al. Blood. 2010 Nov 25;116(22):4532-41. doi: 10.1182/blood-2010-05-283309. Epub 2010 Aug 11. Blood. 2010. PMID: 20702778 Free PMC article.
114 results